CGRP monoclonal antibodies : summary and effectiveness - Migraine

CGRP Monoclonal Antibodies for Chronic Migraine Prevention: Evaluation of Adverse Effects

Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study

Real-world treatment patterns for CGRP mAb

Therapeutic novelties in migraine: new drugs, new hope?, The Journal of Headache and Pain

Toxins, Free Full-Text

Aimovig (erenumab) for the Treatment of Episodic Migraine

Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials - Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul, 2023

Pharmaceuticals, Free Full-Text

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score

Monoclonal Antibodies to CGRP or Its Receptor for Migraine Prevention - ScienceDirect

PDF) CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs

An Overview of New Biologics for Migraine Prophylaxis